On November 25, 2020, Kensington acquired us. The Business Combination was
accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under
this method of accounting, Kensington was treated as the "acquired" company for
financial reporting purposes. Except as otherwise provided herein, our financial
statement presentation includes (1) the results of Legacy QuantumScape and its
consolidated subsidiaries as our accounting predecessor for periods prior to the
completion of the Business Combination, and (2) the results of the Company
(including the consolidation of Legacy QuantumScape and its subsidiaries) for
periods after the completion of the Business Combination.

The following discussion and analysis should be read in conjunction with our
unaudited condensed consolidated financial statements and the related notes
appearing elsewhere in this Report. This discussion may contain forward-looking
statements based upon current expectations that involve risks and uncertainties.
Our actual results may differ materially from those anticipated in these
forward-looking statements as a result of various factors, including those set
forth in the section titled "Risk Factors" as set forth in this Report. Unless
the context otherwise requires, references in this "Management's Discussion and
Analysis of Financial Condition and Results of Operations" to "Legacy
QuantumScape", "the Company", "we", "us" and "our" refer to the business and
operations of Legacy QuantumScape and its consolidated subsidiaries prior to the
Business Combination and to QuantumScape Corporation and its consolidated
subsidiaries, following the closing of the Business Combination.

Overview

We are developing next generation battery technology for EVs and other applications. We believe that our technology will enable a new category of battery that meets the requirements for broader market adoption. The lithium-metal solid-state battery technology that we are developing is being designed to offer greater energy density, longer life, faster charging, and greater safety when compared to today's conventional lithium-ion batteries.



We are a development stage company with no revenue to date, have incurred a net
loss from operations of approximately $90.7 million for the three months ended
March 31, 2022 and an accumulated deficit of approximately $2.1 billion from our
inception through March 31, 2022. We expect to incur significant expenses and
continuing losses for the foreseeable future.

Key Trends, Opportunities and Uncertainties



We are a pre-revenue company. We believe that our performance and future success
depend on several factors that present significant opportunities for us but also
pose significant risks and challenges, including those discussed below and in
the section titled "Risk Factors" appearing elsewhere in this Report.

Product Development



We are developing our battery technology with the goal of beginning
commercialization between 2024 and 2025 via the production of C-sample battery
cells made available for sale to a third party. We have demonstrated
capabilities of our solid-state separator and battery technology in
single-layer, four-layer, 10-layer, and 16-layer solid-state cells. We are now
working to develop A-sample battery cells, to validate the performance of these
cells and to continue to improve yield and performance of our battery cells.

                                       23
--------------------------------------------------------------------------------

Our research and development currently includes programs for the following areas:


Multi-layering. We are working to continue increasing the number of layers in
our cells. We have demonstrated capabilities of our solid-state separator and
battery technology in single-layer, four-layer, and 10-layer solid-state cells
in commercially relevant areas (ranging from approximately 60x75mm to 70x85mm).
In February 2022, we announced early cycling test results for 16-layer cells
also in commercially relevant areas. In April 2022, we announced 16-layer cell
cycling results in our proprietary new cell form factor. In order to advance the
maturity of our prototype cells and produce commercially-viable solid-state
battery cells, we must produce battery cells with dozens of layers, the exact
number of which depends on our customers' requirements. We are targeting two to
four dozen layers for our A-sample battery cells and additional layers for our
B-sample battery cells - depending upon customer preference, cell design
considerations, and other factors. We will need to overcome the developmental
challenges to increase the layer count and implement the appropriate cell design
for our solid-state battery cell.

Continued improvement in the quantity, quality and consistency of our solid-state separator. We are working to improve the quantity, quality and consistency of our solid-state separators, to further improve, among other things, the cycling behavior, power, operating conditions of our cells and to continue to reduce separator thickness.


Improvement of our separator manufacturing process. We have selected a method of
continuous processing found at scale in both the battery and ceramic industries
and are working on continuous improvement of this process, including better
consistency and higher throughput. In addition, we are exploring other
approaches to improve the output and performance of our separator manufacturing.
Regarding consistency, tightening the variability of separator quality results
in better yield. Regarding throughput, increasing the volume of separator
production results in the increased quantities required for higher layer counts
and delivery of more test cells to prospective customers. We are automating our
manufacturing process and purchasing larger-scale manufacturing equipment. We
will need to substantially improve our manufacturing processes to increase
throughput required for higher layer counts and to achieve the cost, performance
and volume levels required for commercial shipments.

                                       24
--------------------------------------------------------------------------------


Continued improvement of the cathode. Our cathodes use a conventional cathode
active material such as NMC mixed with a catholyte. We plan to benefit from
industry cathode chemistry improvements and/or cost reduction, which in the
future may include use of other cathode active materials, including cobalt-free
compositions, including LFP, as well as cathode processing advances such as dry
electrode processing. Over the years, we have developed catholytes made of
differing mixtures of organic polymer and organic liquid electrolyte to optimize
performance across multiple metrics such as voltage, temperature, power, and
safety, among others. We continue to test solid, gel and liquid catholytes in
our cells. The solid catholyte is part of our ongoing research and development
investigation into inorganic catholytes. Our solid-state catholyte platform is
being designed to enable high rates of charge and discharge for even thicker
cathode electrodes, which when combined with a lithium-metal anode, may further
increase cell energy densities.

Our team of over 600 scientists, engineers, technicians, and other staff is
highly motivated and committed to solving these challenges ahead. However, any
delays in the completion of these tasks will require additional cash use and
delay market entry. As we grow our team, expand the size of our engineering line
capacity, and build-out and bring up our QS-0 and QS-1, our rate of cash
utilization will also increase significantly.

Process Development

Our architecture depends on our proprietary solid-state ceramic separator which we will manufacture ourselves. Though our separator's design is unique, its manufacturing relies on well-established, high-volume production processes currently deployed globally in other industries at large scale.



The solid-state separator is being designed to enable our 'anode-free'
architecture. As manufactured, our solid-state battery cell has no anode; the
lithium-metal anode is formed during the first charge of the cell; 100% of the
lithium that forms the anode comes from the cathode material we purchase.
Eliminating the anode bill of materials and associated manufacturing costs found
in conventional lithium-ion cells could result in a meaningful cost of goods
sold advantage for us. In addition, our solid-state battery cell is being
designed to reduce the time and capital-intensity of the formation process step
as compared to conventional lithium-ion manufacturing.

We are focused on the continued expansion of the throughput and capability of
our San Jose, California engineering line as well as the planning and setup of
our QS-0 and planning for our QS-1. As part of the continued expansion of our
throughput we are automating our manufacturing process and purchasing
larger-scale battery-cell manufacturing equipment. We will need to substantially
improve our battery cell manufacturing processes to increase throughput required
for higher numbers of battery cells and to achieve the cost, performance and
volume levels required for commercial shipments.

Continued expansion of the throughput and capability of our San Jose engineering
line and QS-0 serves two purposes. First, the engineering line and QS-0 are
intended to provide a sufficient quantity of solid-state separators and cells
for internal development, customer sampling (including pre A-sample, A-sample,
and B-sample cells), and marking the start of commercialization via production
of C-sample cells made available for sale to a third party. And second, our San
Jose engineering line and QS-0 are intended to provide the basis for continued
manufacturing process development and help inform tool selection and
specifications for equipment for QS-1. Delays in the successful buildout of our
San Jose engineering line and QS-0 may impact both our development and the QS-1
timelines.

We will need to achieve significant cost savings in battery design and
manufacturing, in addition to the cost savings associated with the elimination
of an anode from our solid-state battery cells, while controlling costs
associated with the manufacture of our solid-state separator, including
achieving substantial improvements in throughput and yield required to hit
commercial targets. Further, we will need to capture industry cost savings in
the materials, components, equipment, and processes that we share, notably in
the cathode, cell design, and factory.

Commercialization and Market Focus



As noted above, we will continue developing our battery technology with the goal
of enabling customer prototype sampling in 2022, samples for use in test cars in
2023, and commercialization through the production of C-sample battery cells
made available for sale to a third party, between 2024 and 2025. We are
currently targeting the initial production of C-sample battery cells at QS-0. We
have demonstrated the performance capabilities of our solid-state separator and
battery technology in single-layer, four-layer, and 10-layer solid-state cells
and more recently announced early cycling test results of 16-layer solid-state
cells, in each case in commercially relevant areas (ranging approximately from
60x75mm to 70x85mm). We will work to continue improving quality, consistency,
and throughput and optimize all components of the cell. We will continue to work
to further develop and validate the volume manufacturing processes to enable
high volume manufacturing and minimize manufacturing costs. The funds available
to us will enable us to expand and accelerate research and development
activities and undertake additional initiatives. Finally, we will continue to
use and expand on our engineering line in San Jose to prepare for high volume
manufacturing, to continue to order QS-0 equipment and prepare our QS-0, and to
plan our QS-1 through our joint venture partnership with Volkswagen.

                                       25
--------------------------------------------------------------------------------


QS-1 to be built and run by QSV and the subsequent QS-1 Expansion, would
represent a small fraction of Volkswagen's demand for batteries and implies
vehicle volumes under 2.5% of Volkswagen's total production in 2021, assuming a
100kWh battery pack size. Our goal is to significantly expand the production
capacity of the joint venture, in partnership with Volkswagen, to meet more of
their projected demand. While Volkswagen is the first automotive original
equipment manufacturer ("OEM") that we signed an agreement with the goal of
commercializing vehicles using our battery technology, we intend to work closely
with other OEMs to make our solid-state battery cells widely available over
time. We recently signed an agreement with a fourth OEM, a top ten automaker by
global revenues in which the OEM agreed to collaborate with us on the validation
and testing of our solid-state battery cells with the goal of us providing such
cells to the OEM for inclusion into pre-production prototype vehicles and
ultimately into serial production vehicles. The agreement follows testing of the
Company's early-stage cells by the OEM in its labs. We are currently focused on
automotive EV applications, which have among the most stringent sets of
requirements for batteries. However, we recognize that our solid-state battery
technology has applicability in other large and growing markets including
stationary storage and consumer electronics such as smartphones and wearables
and will explore opportunities in those areas as appropriate.

We believe that our technology enables a variety of business models. In addition
to joint ventures, such as the one with Volkswagen, we may operate solely-owned
manufacturing facilities or license our technology to other manufacturers. We
intend to continue to invest in research and development to improve battery cell
performance, improve manufacturing processes, and reduce cost.

Access to Capital



Following the Business Combination, the March 2021 Public Offering, and assuming
we experience no significant delays in the research and development of our
solid-state battery cells, we believe that our cash resources are sufficient to
fund QS-0 expenses and the initial setup of the QS-1 production facilities.
However, any delays could materially impact us.

Regulatory Landscape



We operate in an industry that is subject to many established environmental
regulations, which have generally become more stringent over time, particularly
in hazardous waste generation and disposal and pollution control. Regulations in
our target markets include economic incentives to purchasers of EVs, tax credits
for EV manufacturers, and economic penalties that may apply to a car
manufacturer based on its fleet-wide emissions which may indirectly benefit us
in that the regulations will expand the market size of EVs. While we expect
environmental regulations to provide a tailwind to our growth, it is possible
for certain regulations to result in margin pressures. Trade restrictions and
tariffs, while historically minimal between the European Union and the United
States where most of our production and sales are expected, are subject to
unknown and unpredictable change that could impact our ability to meet projected
sales or margins.

COVID-19

Beginning in March 2020, the COVID-19 pandemic and the measures imposed to
contain this pandemic have disrupted and may continue to impact the Company's
business. In California, many of the COVID-19 restrictions have been removed,
but there is concern that some or all of these restrictions may be reimposed if
there are new variants (which may be more contagious or severe and may be less
responsive to vaccines or treatments) and resurgences of COVID-19 cases. The
magnitude of the impact of the COVID-19 pandemic on the Company's productivity,
results of operations and financial position, and its disruption to the
Company's business and battery development and timeline, will depend in part, on
the length and severity of these restrictions and on the Company's ability to
conduct business in the ordinary course.

Basis of Presentation



We currently conduct our business through one operating segment. As a
pre-revenue company with no commercial operations, our activities to date have
been limited and were conducted primarily in the United States. Our historical
results are reported under U.S. GAAP and in U.S. dollars. Upon commencement of
commercial operations, we expect to expand our global operations substantially,
including in the United States and the European Union, and as a result we expect
our future results to be sensitive to foreign currency transaction and
translation risks and other financial risks that are not reflected in our
historical financial statements. As a result, we expect that the financial
results we report for periods after we begin commercial operations will not be
comparable to the financial results included in this Report.

Components of Results of Operations



We are a research and development stage company and we have not generated any
revenues to date. Our historical results may not be indicative of our future
results for reasons that may be difficult to anticipate. Accordingly, the
drivers of our future financial results, as well as the components of such
results, may not be comparable to our historical or projected results of
operations.

Operating Expenses

                                       26

--------------------------------------------------------------------------------

Research and Development Expense



To date, our research and development expenses have consisted primarily of
personnel-related expenses for scientists, experienced engineers and technicians
as well as costs associated with the expansion and ramp up of our engineering
and QS-0 facilities in San Jose, including the material and supplies to support
the product development and process engineering efforts. As we ramp up our
engineering operations to complete the development of our solid-state,
lithium-metal batteries and required process engineering to meet automotive cost
targets, we anticipate that research and development expenses will increase
significantly for the foreseeable future as we expand our hiring of scientists,
engineers, and technicians and continue to invest in additional plant and
equipment for product development (e.g. multi-layer cell stacking, packaging
engineering), building prototypes, and testing of battery cells as our team
works to meet the full set of automotive product requirements. We also
recognized significant non-cash stock-based compensation to employees directly
involved in research and development activities. For stock-based compensation
awards with performance and market conditions, such as the awards granted under
our Extraordinary Performance Award Program (the "EPA Program") in December
2021, the non-cash expense recognized is based on a probability assessment of
the performance conditions, and as such, we expect research and development
expenses to fluctuate in the future as the performance conditions are
re-assessed at each reporting period. Further, should the stated market
conditions of the EPA Program grants be achieved prior to the expected
achievement period, we would accelerate the stock-based compensation expense
recognized, which could result in significant fluctuations in research and
development expense recognized in the future. For more information on the EPA
Program and grants thereunder, see Note 9 to our audited consolidated financial
statements elsewhere in this Report.

As we ramp up towards commercial manufacturing operations, we will begin to incur expenses that are directly associated with manufacturing, including allocation of indirect costs from research and development.

General and Administrative Expense



General and administrative expenses consist mainly of personnel-related expenses
for our executive, sales and marketing and other administrative functions and
expenses for director and officer insurance and outside professional services,
including legal, accounting and other advisory services. We are rapidly
expanding our personnel headcount and supporting systems, in anticipation of
planning for and supporting the ramping up of commercial manufacturing
operations and being a public company. Accordingly, we expect our general and
administrative expenses to increase significantly in the near term and for the
foreseeable future. Upon commencement of commercial operations, we also expect
general and administrative expenses to include customer and sales support and
advertising costs. We also recognize significant non-cash stock-based
compensation to executives and certain employees. The non-cash expense
recognized for EPA Program grants is based on a probability assessment of the
performance conditions, and as such, we expect general and administrative
expenses to fluctuate in the future as the performance conditions are
re-assessed at each reporting period. Further, should the stated market
conditions of the EPA Program awards be achieved prior to the expected
achievement period, we would accelerate the stock-based compensation expense
recognized, which could result in significant fluctuations in general and
administrative expense recognized in the future.

As we ramp up towards commercial manufacturing operations, we will begin to incur expenses that are directly associated with manufacturing, including allocation of indirect costs from general and administrative activities.

Other Income (Expense)

Interest Expense

Interest expense consists primarily of interest expense associated with our QS-0 facility lease.



Interest Income

Interest income consists primarily of interest income from marketable securities.

Other Income (Expense)

Our other income (expense) consists of miscellaneous income and expenses such as the gain on the disposal of fixed assets.

Income Tax Expense / Benefit

Our income tax provision consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. We maintain a valuation allowance against the full value of our U.S. and state net deferred tax assets because we believe the recoverability of the tax assets is not more likely than not.


                                       27
--------------------------------------------------------------------------------

Results of Operations

Comparison of the Three Months Ended March 31, 2022 to the Three Months Ended March 31, 2021

The following table sets forth our historical operating results for the periods indicated (amounts in thousands):



                                             Three Months Ended March 31,             $             %
                                               2022                 2021           Change        Change
Operating expenses:
Research and development                  $       61,345       $       29,465     $  31,880           108 %
General and administrative                        29,312               15,210        14,102            93 %
Total operating expenses                          90,657               44,675        45,982           103 %
Loss from operations                             (90,657 )            (44,675 )     (45,982 )         103 %
Other income (loss):
Interest expense                                    (600 )                  -          (600 )         100 %
Interest income                                      816                  247           569           230 %
Change in fair value of assumed common
stock warrant liabilities                              -              (30,764 )      30,764          (100 )%
Other income                                          88                  103           (15 )         (15 )%
Total other income (loss):                           304              (30,414 )      30,718          (101 )%
Net loss                                         (90,353 )            (75,089 )     (15,264 )          20 %
Less: Net loss attributable to
non-controlling interest                              (1 )                (10 )           9           (90 )%
Net loss attributable to common
stockholders                              $      (90,352 )     $      (75,079 )   $ (15,273 )          20 %



Research and Development

The increase in research and development expense in the three months ended March
31, 2022 compared to the three months ended March 31, 2021 primarily resulted
from the $12.0 million increase in personnel cost due to the growth in research
and development headcount to support technology development, an increase of $2.7
million in material supplies and equipment maintenance to support the increase
of research and development cell builds in our commercial form factor, an
increase of $3.6 million related to depreciation and amortization, an increase
of $4.1 million in facility expenses primarily related to the QS-0 facility and
a $2.5 million increase in professional fees, administrative expenses and
outside services to support the growth in product development and process
engineering efforts. Additionally, non-cash stock-based compensation expense
increased by $6.9 million from $6.4 million for the three months ended March 31,
2021 to $13.2 million for the three months ended March 31, 2022 primarily due to
the effect of restricted stock unit ("RSU") granted subsequent to March 31, 2021
and the EPA Program grants in December 2021.

General and Administrative



The increase in general and administrative expenses in the three months ended
March 31, 2022 compared to the three months ended March 31, 2021 primarily
resulted from the $2.8 million increase in professional fees and other corporate
expenses due to costs associated with business growth and an increase of $1.4
million in personnel costs due to the headcount increase to support business
growth. Additionally, non-cash stock-based compensation expense increased by
$9.9 million, from $5.3 million for the three months ended March 31, 2021 to
$15.2 million for the three months ended March 31, 2022 primarily due to the
effect of RSUs granted subsequent to March 31, 2021 and the EPA Program grants
in December 2021.

Interest Expense

The increase in interest expense during the three months ended March 31, 2022
was due to the interest expense associated with a finance lease, which commenced
in May 2021.

Interest Income

The increase in interest income during the three months ended March 31, 2022 compared to the three months ended March 31, 2021 was due to an increase in investments in marketable securities.

Change in Fair Value of Assumed Common Stock Warrant Liability



The change in fair value of Assumed Common Stock Warrant liabilities was due to
the change in the estimated non-cash fair value of the Public and Private
Placement Warrants at the end of each reporting period or through the exercise
of the warrants.

All Assumed Common Stock Warrants were exercised or redeemed as of December 31,
2021, and there was no remaining liability for Assumed Common Stock Warrants as
of December 31, 2021.

                                       28
--------------------------------------------------------------------------------

Liquidity and Capital Resources



As of March 31, 2022 and December 31, 2021, our principal sources of liquidity
were our cash and cash equivalents and marketable securities in the amount of
approximately $1.3 billion and $1.4 billion, respectively. Our cash equivalents
are invested in U.S. money market funds, U.S. Treasury bonds and commercial
paper. Our marketable securities are invested in U.S. Treasury notes and bonds,
commercial paper, and corporate notes and bonds.

We have yet to generate any revenue from our business operations. To date, we
have funded our capital expenditure and working capital requirements through
equity as further discussed below. Our ability to successfully develop our
products, commence commercial operations and expand our business will depend on
many factors, including our working capital needs, the availability of equity or
debt financing and, over time, our ability to generate cash flows from
operations.

Prior to the Business Combination, we financed our operations primarily from the
sales of redeemable convertible preferred stock. In connection with the Business
Combination, we received net cash proceeds of approximately $676.9 million.
Additionally, after the Business Combination, during the year ended December 31,
2020, we received proceeds of approximately $99.8 million from the Series F
Preferred Stock Purchase Agreements.

During the year ended December 31, 2021, we completed the March 2021 Public
Offering for aggregate net cash proceeds of $462.9 million. In April 2021, we
received $100 million from VGA pursuant to our achievement of the technical
milestone specified in the Series F Preferred Stock Purchase Agreements. Also,
during the year ended December 31, 2021, all Assumed Common Stock Warrants were
exercised or redeemed and we received net proceeds of $151.4 million.

We believe that our cash on hand will be sufficient to meet our working capital
and capital expenditure requirements for a period of at least twelve months from
the date of this Report. We believe it is also sufficient to fund QS-0 expenses,
and our initial start of QS-1 production. We may, however, need additional cash
resources due to changed business conditions or other developments, including
unanticipated delays in negotiations with automotive OEMs and tier-one
automotive suppliers or other suppliers, supply chain challenges, disruptions
due to the COVID-19 pandemic, competitive pressures, and regulatory
developments, among others. To the extent that our current resources are
insufficient to satisfy our cash requirements, we may need to seek additional
equity or debt financing. If such financing is not available, or if the
financing terms are less desirable than we expect, we may be forced to decrease
our level of investment in product development or scale back our operations,
which could have an adverse impact on our business and financial prospects.

Cash Flows

The following table provides a summary of our cash flow data for the periods indicated (amounts in thousands):



                                               Three Months Ended March 31,
                                                 2022                 2021

Net cash used in operating activities $ (47,401 ) $ (21,536 ) Net cash provided by investing activities

            8,427               

97,839


Net cash provided by financing activities            1,287              

572,822

Cash Flows from Operating Activities



Our cash flows used in operating activities to date have been primarily driven
by the growth in our underlying business to support the research and development
of our next generation of battery technology. As we continue to ramp up hiring
for technical headcount to accelerate our engineering efforts ahead of starting
the pre-pilot and pilot line operations, we expect our cash used in operating
activities to increase significantly before we start to generate any material
cash flows from our business. To support our research and development activities
and our plan to expand our pre-pilot manufacturing capability, we are expecting
cash payments of $5.0 million during the next twelve months and $79.5 million
thereafter for the operating lease commitments as of March 31, 2022. The lease
commenced in April 2022 results in cash payments of $0.4 million in the next
twelve months and $7.5 million thereafter. From time to time we also enter into
non-cancellable service and purchase commitments. We are expecting cash used in
operating activities to include payments of $0.8 million in the next twelve
months and $1.2 million thereafter through 2024 for our non-cancellable service
commitments as of March 31, 2022 and payments of $0.5 million in the next twelve
months and $8.7 million thereafter for the non-cancellable purchase commitment
we entered into in April 2022. As we complete the development of our
solid-state, lithium-metal batteries and required process engineering to meet
automotive cost targets, we anticipate that research and development operating
expenses will increase significantly for the foreseeable future.

Cash used in operating activities for the three months ended March 31, 2022 was
primarily driven by a net loss of $90.4 million offset by non-cash of $28.5
million related to stock-based compensation, non-cash expense of $2.2 million
related to amortization of premiums and accretion of discounts on marketable
securities, and non-cash expense of $4.7 million related to depreciation and
amortization. This was partially offset by a net increase of $2.7 million in
accounts payable and total accrued liabilities. The increase in accounts payable
and accrued liabilities was driven by higher period-over-period spending in
payroll, materials and supplies, professional services and general and
administrative to support the growth of the business, specifically in the
research and development of our battery technology.

Cash used in operating activities for the three months ended March 31, 2021 was
primarily driven by a net loss of $75.1 million offset by the non-cash expenses
including $30.8 million for the change in fair value of Assumed Common Stock
Warrant liabilities, $11.7

                                       29
--------------------------------------------------------------------------------


million related to stock-based compensation expense, $2.4 million related to
amortization of premiums and accretion of discounts on marketable securities,
and $2.2 million related to depreciation and amortization expense.

Cash Flows from Investing Activities



Our cash flows from investing activities to date have been comprised of
purchases of property and equipment and purchases, maturities and sales of our
marketable securities. We expect the level of capital investment to increase
substantially in the near future as we fully build out our engineering lines as
well as acquire the property and equipment for QS-0.

Cash provided by investing activities for the three months ended March 31, 2022
primarily consists of the maturity and sale of marketable securities of $218.5
million and $13.1 million, respectively, offset by $183.9 million used for the
purchase of marketable securities. Cash provided by investing activities also
reflects $39.3 million of cash used for various leasehold improvements, fixtures
and structures, lab equipment, office and software to primarily support our R&D
activities.

Cash provided by investing activities for the three months ended March 31, 2021
primarily consists of proceeds from the maturities of marketable securities of
$111.0 million. These proceeds were offset by $13.3 million of cash used for
various property and equipment expenditures.

Cash Flows from Financing Activities



Our cash flows from financing activities primarily consist of proceeds from the
exercise of stock options. Finance lease commitment for QS-0 will result in net
cash payments of $2.4 million in the next twelve months and payments of $53.2
million thereafter.

Cash provided by financing activities during the three months ended March 31, 2022 is primarily due to $1.3 million received from the exercise of stock options.



Cash provided by financing activities during the three months ended March 31,
2021 is primarily related to $463.8 million in net proceeds received from the
March 2021 Public Offering, $109.1 million received from the exercise of Public
Warrants, and approximately $0.9 million received from the exercise of stock
options.


Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet arrangements, as defined under SEC rules.

Critical Accounting Policies and Estimates



Our financial statements have been prepared in accordance with U.S. GAAP. In the
preparation of these condensed consolidated financial statements, we are
required to use judgment in making estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities as of the date of the financial statements, as well as
the reported expenses incurred during the reporting periods.

We consider an accounting judgment, estimate or assumption to be critical when
(1) the estimate or assumption is complex in nature or requires a high degree of
judgment and (2) the use of different judgments, estimates and assumptions could
have a material impact on the consolidated financial statements. Our significant
accounting policies are described in Note 2 to our condensed consolidated
financial statements in this Report. Our critical accounting policies and
estimates were described in Part II, Item 7, Critical Accounting Policies and
Estimates in our Annual Report. There have been no material changes to our
critical accounting policies and estimates since our Annual Report.

Recent Accounting Pronouncements



See   Note 3   to the condensed consolidated financial statements in this Report
for more information about recent accounting pronouncements, the timing of their
adoption, and, to the extent it has made one, of their potential impact on our
financial condition and its results of operations and cash flows.

                                       30

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses